TNFR2 is required for RIP1-dependent cell death in human leukemia.

Saved in:
Bibliographic Details
Title: TNFR2 is required for RIP1-dependent cell death in human leukemia.
Authors: Aguadé-Gorgorió J; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., McComb S; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Eckert C; Department of Pediatric Oncology/Hematology, Charité Medical University Berlin, Berlin, Germany., Guinot A; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Marovca B; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Mezzatesta C; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Jenni S; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Abduli L; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Schrappe M; Department of General Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany; and., Dobay MP; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Stanulla M; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany., von Stackelberg A; Department of Pediatric Oncology/Hematology, Charité Medical University Berlin, Berlin, Germany., Cario G; Department of General Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany; and., Bourquin JP; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Bornhauser BC; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.
Source: Blood advances [Blood Adv] 2020 Oct 13; Vol. 4 (19), pp. 4823-4833.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33027529
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: TNFR2 is required for RIP1-dependent cell death in human leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Aguadé-Gorgorió+J%22">Aguadé-Gorgorió J</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22McComb+S%22">McComb S</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Eckert+C%22">Eckert C</searchLink>; Department of Pediatric Oncology/Hematology, Charité Medical University Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Guinot+A%22">Guinot A</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Marovca+B%22">Marovca B</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mezzatesta+C%22">Mezzatesta C</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jenni+S%22">Jenni S</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Abduli+L%22">Abduli L</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schrappe+M%22">Schrappe M</searchLink>; Department of General Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany; and.<br /><searchLink fieldCode="AU" term="%22Dobay+MP%22">Dobay MP</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Stanulla+M%22">Stanulla M</searchLink>; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22von+Stackelberg+A%22">von Stackelberg A</searchLink>; Department of Pediatric Oncology/Hematology, Charité Medical University Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Cario+G%22">Cario G</searchLink>; Department of General Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany; and.<br /><searchLink fieldCode="AU" term="%22Bourquin+JP%22">Bourquin JP</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bornhauser+BC%22">Bornhauser BC</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2020 Oct 13; Vol. 4 (19), pp. 4823-4833.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33027529
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2019000796
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4823
    Titles:
      – TitleFull: TNFR2 is required for RIP1-dependent cell death in human leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Aguadé-Gorgorió J
      – PersonEntity:
          Name:
            NameFull: McComb S
      – PersonEntity:
          Name:
            NameFull: Eckert C
      – PersonEntity:
          Name:
            NameFull: Guinot A
      – PersonEntity:
          Name:
            NameFull: Marovca B
      – PersonEntity:
          Name:
            NameFull: Mezzatesta C
      – PersonEntity:
          Name:
            NameFull: Jenni S
      – PersonEntity:
          Name:
            NameFull: Abduli L
      – PersonEntity:
          Name:
            NameFull: Schrappe M
      – PersonEntity:
          Name:
            NameFull: Dobay MP
      – PersonEntity:
          Name:
            NameFull: Stanulla M
      – PersonEntity:
          Name:
            NameFull: von Stackelberg A
      – PersonEntity:
          Name:
            NameFull: Cario G
      – PersonEntity:
          Name:
            NameFull: Bourquin JP
      – PersonEntity:
          Name:
            NameFull: Bornhauser BC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 10
              Text: 2020 Oct 13
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 19
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1